Sander Brooks
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 11, 2023
Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers.S Brooks, Rgja Zuiker, C Bleys
|Nov 18, 2020
Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.Benjamin Berger, Sander Brooks, Rob Zuiker
|Oct 24, 2019
Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration.Clemens Muehlan, Margaux Boehler, Sander Brooks
|Jan 16, 2019
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.Sander Brooks, Gabriël E Jacobs, Peter de Boer
Pageof 1
